Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (97)

1

Favipiravir, remdesivir, and lopinavir : metabolites, degradation products and their analytical methods

enthalten in: Drug metabolism reviews | 2024

von Hoseininezhad-Namin, M. | Rahimpour, E. | Jouyban, A.

2

Remdesivir and three other drugs for hospitalised patients with COVID-19 : final results of the WHO Solidarity randomised trial and updated meta-analyses

enthalten in: Lancet (London, England) | 2022

von WHO Solidarity Trial Consortium | Pan, H. | Peto, R. | +98

CommentIn: Lancet. 2022 May 21;399(10339):1918-1920. - PMID 35512729

3

Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19 : systematic review and meta-analysis of randomised trials

enthalten in: BMJ open | 2022

von Izcovich, A. | Siemieniuk, R. | Bartoszko, J. | +12

4

Understanding the binding mechanism for potential inhibition of SARS-CoV-2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine

enthalten in: Journal of cellular biochemistry | 2022

von Choudhury, M. | Dhanabalan, A. | Goswami, N.

5

Synthetic Attempts Towards Eminent Anti-viral Candidates of SARS-CoV

enthalten in: Mini reviews in medicinal chemistry | 2022

von Kundu, S. | Sarkar, D.

6

COVID-19 : potential therapeutics for pediatric patients

enthalten in: Pharmacological reports : PR | 2021

von Younis, N. | Zareef, R. | Fakhri, G. | +3

7

Pharmacological interventions for COVID-19 : a systematic review of observational studies and clinical trials

enthalten in: Expert review of anti-infective therapy | 2021

von Bokharee, N. | Khan, Y. | Khokhar, A. | +3

8

Clinical efficacy of antiviral agents against coronavirus disease 2019 : A systematic review of randomized controlled trials

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2021

von Lai, C. | Chao, C. | Hsueh, P.

9

Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19

enthalten in: Journal of medical virology | 2021

von Haji Aghajani, M. | Moradi, O. | Amini, H. | +4

10

Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics

enthalten in: Scientific reports | 2021

von Ambrus, C. | Bakos, �. | Sarkadi, B. | +2

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]